Previous 10 | Next 10 |
FinancialBuzz.com News Commentary New York, NY (7/13/2020) – In a time of a pandemic, new innovations solutions to health problems are in need. One group of devices that got more attention as a result are wearable devices. The growing popularity of the Internet of Things (IoT) and conne...
Will These Be On Your List Of Penny Stocks This Month? If you’ve followed penny stocks , you know they can move in phases. Earlier in June, for instance, we saw a mad-dash by retail traders looking for penny stocks to buy . Then at the start of July, things cooled off a bit. This does...
Aytu BioScience (NASDAQ: AYTU ) has signed a distribution agreement with Apollo Med Innovations to distribute the COVID-19 IgG/IgM Rapid Test Cassette to Apollo's network of over 1,000 practices across the U.S. More news on: Aytu BioScience, Inc., Healthcare stocks news, Stocks on ...
Apollo Med Innovations Introduces Novel Research-Based Testing Approach to Offer COVID-19 Antibody Testing to Nationwide Network of Over 1,000 Medical Clinics and Recently Launched Mobile Testing Platform ENGLEWOOD, CO / ACCESSWIRE / July 10, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), ...
MDC Partners (NASDAQ: MDCA ) +169% on potential business combination with Stagwell. More news on: MDC Partners Inc., Vaxart, Inc., iBio, Inc., Stocks on the move, , Read more ...
These Penny Stocks Have Seen Explosive Moves; Is That The Case Right Now? Penny stocks are quiet until they’re not. Over sold penny stocks are bad until they aren’t. Illiquid stocks under $5 aren’t worth it until they are. At the end of the day, these cheap stocks can pres...
Funny what can happen in three months. On March 9 th , 2020, Aytu BioScience ( AYTU ) closed at $0.35 per share and was in danger of being delisted from NASDAQ. Three months later, the company is now trading at $1.47 per share, more than quadruple the aforementioned March price. Of course, mos...
Aytu BioScience (NASDAQ: AYTU ) announces results from a National Cancer Institute evaluation of the performance of its COVID-19 IgG/IgM rapid antibody blood test. Results from a 110-sample panel (30 confirmed positives, 80 confirmed negatives): More news on: Aytu BioScience, Inc., Healt...
National Cancer Institute's (NCI) analysis of COVID-19 IgG/IgM Rapid Test Cassette Reported 100% Combined Sensitivity, and 97.5% Combined Specificity for the Lateral Flow Immunoassay ENGLEWOOD, CO / ACCESSWIRE / June 9, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceuti...
Aytu BioScience (NASDAQ: AYTU ) is set to join the Russell 3000 Index, effective after the close of the US markets on June 26. More news on: Aytu BioScience, Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Company receives proceeds of $3.5 million through exercise of warrants, a portion of which was used to pay down debt Interest rate on new $13.0 million term loan reduced by approximately 350 basis points today, potentially saving the Company $1.3 million over the life of the term loan T...
Phoenix, Arizona and New York, New York--(Newsfile Corp. - May 29, 2024) - Lytham Partners, a leading investor relations and corporate access firm, today announced the schedule for its Spring 2024 Investor Conference taking place virtually on May 30, 2024. More than 40 companies will be available...
DENVER, CO / ACCESSWIRE / May 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that Josh Disbrow, CEO, will participate in a webcasted fireside chat and host one-on-one meetings with inv...